Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States

NCT02867722 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT02867722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02867722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2020
Completion date
December 31, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis, non-melanoma skin cancer